NAP1L5, first identified in the human liver malignancy as an imprinted gene, was also found to be hypomethylated in congenital heart diseases (Harada et al., 2002; Smith et al., 2003; Chang et al., 2021). Here, NAP1L5 is linked to congenital heart disease.